Those aiming for above-average market returns often engage in the meticulous process of stock picking. Choosing the right stocks can make a substantial difference in your wealth.
60 Degrees Pharmaceuticals Inc (NASDAQ: SXTP) closed the day trading at $2.16 down -14.09% from the previous closing price of $2.52. In other words, the price has decreased by -$14.09 from its previous closing price. On the day, 2.92 million shares were traded. SXTP stock price reached its highest trading level at $2.575 during the session, while it also had its lowest trading level at $2.1301.
Ratios:
For a better understanding of SXTP, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 2.71 and its Current Ratio is at 3.13. In the meantime, Its Debt-to-Equity ratio is 0.04 whereas as Long-Term Debt/Eq ratio is at 0.04.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jun 03 ’25 when XU CHERYL bought 5,000 shares for $2.88 per share. The transaction valued at 14,410 led to the insider holds 15,816 shares of the business.
XU CHERYL bought 6,000 shares of SXTP for $9,375 on Dec 13 ’24. The Director now owns 52,078 shares after completing the transaction at $1.56 per share. On Dec 12 ’24, another insider, XU CHERYL, who serves as the Director of the company, bought 5,000 shares for $1.82 each. As a result, the insider paid 9,125 and bolstered with 46,078 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, SXTP now has a Market Capitalization of 3188806 and an Enterprise Value of 9680619. For the stock, the TTM Price-to-Sale (P/S) ratio is 4.03. Its current Enterprise Value per Revenue stands at 12.066 whereas that against EBITDA is -0.947.
Stock Price History:
The Beta on a monthly basis for SXTP is 2.76, which has changed by -0.8457977 over the last 52 weeks, in comparison to a change of 0.10611236 over the same period for the S&P500. Over the past 52 weeks, SXTP has reached a high of $35.99, while it has fallen to a 52-week low of $1.41. The 50-Day Moving Average of the stock is -10.23%, while the 200-Day Moving Average is calculated to be -42.00%.
Shares Statistics:
Over the past 3-months, SXTP traded about 195.53K shares per day on average, while over the past 10 days, SXTP traded about 366720 shares per day. A total of 1.47M shares are outstanding, with a floating share count of 1.37M. Insiders hold about 6.91% of the company’s shares, while institutions hold 2.04% stake in the company. Shares short for SXTP as of 1749772800 were 37468 with a Short Ratio of 0.29, compared to 1747267200 on 32529. Therefore, it implies a Short% of Shares Outstanding of 37468 and a Short% of Float of 2.5999999.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
Earnings Estimates
The current market rating for 60 Degrees Pharmaceuticals Inc (SXTP) reflects the collective analysis of 1.0 analysts closely monitoring its performance.The consensus estimate for the next quarter is -$1.21, with high estimates of -$1.21 and low estimates of -$1.21.
Analysts are recommending an EPS of between -$4.95 and -$4.95 for the fiscal current year, implying an average EPS of -$4.95. EPS for the following year is -$5.36, with 1.0 analysts recommending between -$5.36 and -$5.36.
Revenue Estimates
1 analysts predict $320k in revenue for the current quarter. It ranges from a high estimate of $320k to a low estimate of $320k. As of the current estimate, 60 Degrees Pharmaceuticals Inc’s year-ago sales were $124.97kFor the next quarter, 1 analysts are estimating revenue of $380k. There is a high estimate of $380k for the next quarter, whereas the lowest estimate is $380k.
A total of 1 analysts have provided revenue estimates for SXTP’s current fiscal year. The highest revenue estimate was $1.4M, while the lowest revenue estimate was $1.4M, resulting in an average revenue estimate of $1.4M. In the same quarter a year ago, actual revenue was $607.57kBased on 1 analysts’ estimates, the company’s revenue will be $2.22M in the next fiscal year. The high estimate is $2.22M and the low estimate is $2.22M.
